Clinical characteristics and risk factors for severe scrub typhus in pediatric and elderly patients

PLoS Negl Trop Dis. 2022 Apr 29;16(4):e0010357. doi: 10.1371/journal.pntd.0010357. eCollection 2022 Apr.

Abstract

Background: Scrub typhus (ST) is a life-threatening infectious disease if appropriate treatment is unavailable. Large discrepancy of clinical severity of ST patients was reported among age groups, and the underlying risk factors for severe disease are unclear.

Methods: Clinical and epidemiological data of ST patients were collected in 55 surveillance hospitals located in Guangzhou City, China, from 2012 to 2018. Severe prognosis and related factors were determined and compared between pediatric and elderly patients.

Results: A total of 2,074 ST patients including 209 pediatric patients and 1,865 elderly patients were included, with a comparable disease severity rate of 11.0% (95% CI 7.1%-16.1%) and 10.3% (95% CI 9.0%-11.8%). Different frequencies of clinical characteristics including lymphadenopathy, skin rash, enlarged tonsils, etc. were observed between pediatric and elderly patients. Presence of peripheral edema and decreased hemoglobin were the most important predictors of severe illness in pediatric patients with adjusted ORs by 38.99 (9.96-152.67, p<0.001) and 13.22 (1.54-113.50, p = 0.019), respectively, while presence of dyspnea and increased total bilirubin were the potential determinants of severe disease in elderly patients with adjusted ORs by 11.69 (7.33-18.64, p<0.001) and 3.17 (1.97-5.11, p<0.001), respectively. Compared with pediatric patients, elderly patients were more likely to receive doxycycline (64.8% v.s 9.9%, p<0.001), while less likely to receive azithromycin therapy (5.0% v.s 41.1%, p<0.001).

Conclusion: The disease severity rate is comparable between pediatric and elderly ST patients, while different clinical features and laboratory indicators were associated with development of severe complications for pediatric and elderly patients, which is helpful for diagnosis and progress assessment of disease for ST patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Child
  • China / epidemiology
  • Doxycycline / therapeutic use
  • Humans
  • Risk Factors
  • Scrub Typhus* / complications
  • Scrub Typhus* / drug therapy
  • Scrub Typhus* / epidemiology
  • Severity of Illness Index

Substances

  • Doxycycline

Grants and funding

This study was supported by the Natural Science Foundation of China (81825019 to WL, 81722041 to HL), the Science and Technology Plan Grant of Guangzhou (202102080035 to YHW), and the Key Research and Development Program of China (2019YFC1200604 to LQF, 2021YFC2302004 to BGJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.